Abstract
In 2008, the U.S. market for drug eluting stents was valued at $1.95 billion,
representing an increase of 1.6% over 2007. Overall average selling prices are
predicted to decrease over the forecast period. Additional products included
in this report: Bioabsorbable Stents, Bifurcated Stentsand bare-metal stents.
|